Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept for Uveitis in Juvenile Rheumatoid Arthritis
NCT00001862Phase 2Completed
- Sponsor
- National Eye Institute
- Start
- Feb 1999
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in uveitis comparing Etanercept with Placebo (2 arms). Primary endpoints: Occurrence of any severe adverse event at 12 months, Measure of anterior chamber cells at 12 months and 1 more. Started Feb 1999; status: completed.
02
Drugs
etanercept
03
Conditions
uveitis
Beyond the preview
Go deeper on NCT00001862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001862.